Year |
Citation |
Score |
2022 |
Racz RR, Kollo M, Racz G, Bulz C, Ackels T, Warner T, Wray W, Kiskin N, Chen C, Ye Z, de Hoz L, Rancz E, Schaefer AT. jULIEs: nanostructured polytrodes for low traumatic extracellular recordings and stimulation in the mammalian brain. Journal of Neural Engineering. PMID 35108701 DOI: 10.1088/1741-2552/ac514f |
0.44 |
|
2022 |
Sakuma R, Lin KT, Kim S, Kimura F, Kajihara Y. Passive near-field imaging via grating-based spectroscopy. The Review of Scientific Instruments. 93: 013704. PMID 35104953 DOI: 10.1063/5.0059498 |
0.36 |
|
2022 |
Wang G, Mohanty B, Williams ML, Doak BC, Dhouib R, Totsika M, McMahon R, Sharma G, Zheng D, Bentley MR, Chin YK, Horne J, Chalmers DK, Heras B, Scanlon MJ. Selective binding of small molecules to Vibrio cholerae DsbA offers a starting point for the design of novel antibacterials. Chemmedchem. PMID 34978144 DOI: 10.1002/cmdc.202100673 |
0.04 |
|
2021 |
Park JR, Verderosa AD, Totsika M, Hoogenboom R, Dargaville TR. Thermoresponsive Polymer-Antibiotic Conjugates Based on Gradient Copolymers of 2-Oxazoline and 2-Oxazine. Biomacromolecules. PMID 34726387 DOI: 10.1021/acs.biomac.1c01133 |
0.16 |
|
2021 |
Santos-Martin C, Wang G, Subedi P, Hor L, Totsika M, Paxman JJ, Heras B. Structural bioinformatic analysis of DsbA proteins and their pathogenicity associated substrates. Computational and Structural Biotechnology Journal. 19: 4725-4737. PMID 34504665 DOI: 10.1016/j.csbj.2021.08.018 |
0.04 |
|
2021 |
Duncan LF, Wang G, Ilyichova OV, Dhouib R, Totsika M, Scanlon MJ, Heras B, Abbott BM. Elaboration of a benzofuran scaffold and evaluation of binding affinity and inhibition of Escherichia coli DsbA: A fragment-based drug design approach to novel antivirulence compounds. Bioorganic & Medicinal Chemistry. 45: 116315. PMID 34364222 DOI: 10.1016/j.bmc.2021.116315 |
0.08 |
|
2021 |
Dhouib R, Vagenas D, Hong Y, Verderosa AD, Martin JL, Heras B, Totsika M. Antivirulence DsbA inhibitors attenuate serovar Typhimurium fitness without detectable resistance. Faseb Bioadvances. 3: 231-242. PMID 33842848 DOI: 10.1096/fba.2020-00100 |
0.2 |
|
2021 |
Subedi P, Paxman JJ, Wang G, Hor L, Hong Y, Verderosa AD, Whitten AE, Panjikar S, Santos-Martin CF, Martin JL, Totsika M, Heras B. BcfH is a trimeric thioredoxin-like bifunctional enzyme with both thiol oxidase and disulfide isomerase activities. Antioxidants & Redox Signaling. PMID 33607928 DOI: 10.1089/ars.2020.8218 |
0.24 |
|
2021 |
Lim Y, Tang KD, Karpe AV, Beale DJ, Totsika M, Kenny L, Morrison M, Punyadeera C. Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer. Head & Neck. PMID 33527579 DOI: 10.1002/hed.26619 |
0.04 |
|
2021 |
Verderosa AD, Dhouib R, Hong Y, Anderson TK, Heras B, Totsika M. A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics. Scientific Reports. 11: 1569. PMID 33452354 DOI: 10.1038/s41598-021-81007-y |
0.44 |
|
2020 |
Bentley MR, Ilyichova OV, Wang G, Williams ML, Sharma G, Alwan WS, Whitehouse RL, Mohanty B, Scammells PJ, Heras B, Martin JL, Totsika M, Capuano B, Doak B, Scanlon MJ. Rapid elaboration of fragments into leads by X-ray crystallographic screening of parallel chemical libraries (REFiL). Journal of Medicinal Chemistry. PMID 32529824 DOI: 10.1021/acs.jmedchem.0c00111 |
0.01 |
|
2019 |
Verderosa AD, Totsika M, Fairfull-Smith KE. Bacterial Biofilm Eradication Agents: A Current Review. Frontiers in Chemistry. 7: 824. PMID 31850313 DOI: 10.3389/fchem.2019.00824 |
0.16 |
|
2019 |
Verderosa AD, Dhouib R, Fairfull-Smith KE, Totsika M. Nitroxide Functionalized Antibiotics Are Promising Eradication Agents against Staphylococcus aureus Biofilms. Antimicrobial Agents and Chemotherapy. 64. PMID 31636066 DOI: 10.1128/AAC.01685-19 |
0.2 |
|
2019 |
Verderosa AD, Harris J, Dhouib R, Totsika M, Fairfull-Smith KE. Eradicating uropathogenic biofilms with a ciprofloxacin-dinitroxide conjugate. Medchemcomm. 10: 699-711. PMID 31191860 DOI: 10.1039/c9md00062c |
0.08 |
|
2019 |
Verderosa AD, Dhouib R, Fairfull-Smith KE, Totsika M. Profluorescent Fluoroquinolone-Nitroxides for Investigating Antibiotic⁻Bacterial Interactions. Antibiotics (Basel, Switzerland). 8. PMID 30836686 DOI: 10.3390/antibiotics8010019 |
0.08 |
|
2019 |
Furlong EJ, Lo AW, Kurth F, Premkumar L, Totsika M, Achard MES, Halili MA, Heras B, Whitten AE, Choudhury HG, Schembri MA, Martin JL. Author Correction: A shape-shifting redox foldase contributes to Proteus mirabilis copper resistance. Nature Communications. 10: 976. PMID 30824772 DOI: 10.1038/s41467-019-08920-9 |
0.01 |
|
2019 |
Tan A, Li WS, Verderosa AD, Blakeway LV, D Mubaiwa T, Totsika M, Seib KL. Moraxella catarrhalis NucM is an entry nuclease involved in extracellular DNA and RNA degradation, cell competence and biofilm scaffolding. Scientific Reports. 9: 2579. PMID 30796312 DOI: 10.1038/s41598-019-39374-0 |
0.01 |
|
2018 |
Zhan J, Jia H, Semchenko EA, Bian Y, Zhou AM, Li Z, Yang Y, Wang J, Sarkar S, Totsika M, Blanchard H, Jen FE, Ye Q, Haselhorst T, Jennings MP, et al. Self-derived structure-disrupting peptides targeting methionine aminopeptidase in pathogenic bacteria: a new strategy to generate antimicrobial peptides. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201700613RR. PMID 30260702 DOI: 10.1096/Fj.201700613Rr |
0.24 |
|
2018 |
Lim Y, Fukuma N, Totsika M, Kenny L, Morrison M, Punyadeera C. The Performance of an Oral Microbiome Biomarker Panel in Predicting Oral Cavity and Oropharyngeal Cancers. Frontiers in Cellular and Infection Microbiology. 8: 267. PMID 30123780 DOI: 10.3389/fcimb.2018.00267 |
0.04 |
|
2018 |
Sarkar S, Hutton ML, Vagenas D, Ruter R, Schüller S, Lyras D, Schembri MA, Totsika M. Intestinal Colonization Traits of Pandemic Multidrug-Resistant Escherichia coli ST131. The Journal of Infectious Diseases. PMID 29471349 DOI: 10.1093/infdis/jiy031 |
0.08 |
|
2017 |
Totsika M, Vagenas D, Paxman JJ, Wang G, Dhouib R, Sharma P, Martin JL, Scanlon MJ, Heras B. INHIBITION OF DIVERSE DsbA ENZYMES IN MULTI-DsbA ENCODING PATHOGENS. Antioxidants & Redox Signaling. PMID 29237285 DOI: 10.1089/ars.2017.7104 |
0.01 |
|
2017 |
Lim Y, Totsika M, Morrison M, Punyadeera C. Oral Microbiome: A New Biomarker Reservoir for Oral and Oropharyngeal Cancers. Theranostics. 7: 4313-4321. PMID 29158828 DOI: 10.7150/thno.21804 |
0.12 |
|
2017 |
Martinez-Gil M, Goh KGK, Rackaityte E, Sakamoto C, Audrain B, Moriel DG, Totsika M, Ghigo JM, Schembri MA, Beloin C. YeeJ is an inverse autotransporter from Escherichia coli that binds to peptidoglycan and promotes biofilm formation. Scientific Reports. 7: 11326. PMID 28900103 DOI: 10.1038/s41598-017-10902-0 |
0.01 |
|
2017 |
Lim Y, Totsika M, Morrison M, Punyadeera C. The saliva microbiome profiles are minimally affected by collection method or DNA extraction protocols. Scientific Reports. 7: 8523. PMID 28819242 DOI: 10.1038/s41598-017-07885-3 |
0.12 |
|
2017 |
Furlong EJ, Lo AW, Kurth F, Premkumar L, Totsika M, Achard MES, Halili MA, Heras B, Whitten AE, Choudhury HG, Schembri MA, Martin JL. A shape-shifting redox foldase contributes to Proteus mirabilis copper resistance. Nature Communications. 8: 16065. PMID 28722010 DOI: 10.1038/ncomms16065 |
0.04 |
|
2017 |
Hong Y, Liu MA, Reeves PR. Progress in our understanding of Wzx flippase for translocation of bacterial membrane lipid-linked oligosaccharide. Journal of Bacteriology. PMID 28696276 DOI: 10.1128/Jb.00154-17 |
0.68 |
|
2016 |
Shepherd M, Achard ME, Idris A, Totsika M, Phan MD, Peters KM, Sarkar S, Ribeiro CA, Holyoake LV, Ladakis D, Ulett GC, Sweet MJ, Poole RK, McEwan AG, Schembri MA. The cytochrome bd-I respiratory oxidase augments survival of multidrug-resistant Escherichia coli during infection. Scientific Reports. 6: 35285. PMID 27767067 DOI: 10.1038/srep35285 |
0.01 |
|
2016 |
Tan L, Moriel DG, Totsika M, Beatson SA, Schembri MA. Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli. Plos One. 11: e0162391. PMID 27598999 DOI: 10.1371/journal.pone.0162391 |
0.08 |
|
2016 |
Sarkar S, Roberts LW, Phan MD, Tan L, Lo AW, Peters KM, Paterson DL, Upton M, Ulett GC, Beatson SA, Totsika M, Schembri MA. Comprehensive analysis of type 1 fimbriae regulation in fimB-null strains from the multidrug resistant Escherichia coli ST131 clone. Molecular Microbiology. PMID 27309594 DOI: 10.1111/mmi.13442 |
0.04 |
|
2016 |
Sarkar S, Vagenas D, Schembri MA, Totsika M. Biofilm Formation By Multidrug Resistant Escherichia coli ST131 Is Dependent on Type 1 Fimbriae and Assay Conditions. Pathogens and Disease. PMID 26940589 DOI: 10.1093/femspd/ftw013 |
0.01 |
|
2016 |
Nichols KB, Totsika M, Moriel DG, Lo AW, Yang J, Wurpel DJ, Rossiter AE, Strugnell RA, Henderson IR, Ulett GC, Beatson SA, Schembri MA. Molecular characterisation of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli. Journal of Bacteriology. PMID 26858103 DOI: 10.1128/JB.00791-15 |
0.08 |
|
2016 |
Wurpel DJ, Totsika M, Allsopp LP, Webb RI, Moriel DG, Schembri MA. Comparative proteomics of uropathogenic Escherichia coli during growth in human urine identify UCA-like (UCL) fimbriae as an adherence factor involved in biofilm formation and binding to uroepithelial cells. Journal of Proteomics. 131: 177-89. PMID 26546558 DOI: 10.1016/j.jprot.2015.11.001 |
0.01 |
|
2015 |
Kakkanat A, Totsika M, Schaale K, Duell BL, Lo AW, Phan MD, Moriel DG, Beatson SA, Sweet MJ, Ulett GC, Schembri MA. The role of H4 flagella in Escherichia coli ST131 virulence. Scientific Reports. 5: 16149. PMID 26548325 DOI: 10.1038/srep16149 |
0.01 |
|
2015 |
Schaale K, Peters KM, Murthy AM, Fritzsche AK, Phan MD, Totsika M, Robertson AA, Nichols KB, Cooper MA, Stacey KJ, Ulett GC, Schroder K, Schembri MA, Sweet MJ. Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli. Mucosal Immunology. PMID 25993444 DOI: 10.1038/mi.2015.44 |
0.01 |
|
2015 |
Liu MA, Stent TL, Hong Y, Reeves PR. Inefficient translocation of a truncated O unit by a Salmonella Wzx affects both O-antigen production and cell growth. Fems Microbiology Letters. 362. PMID 25837817 DOI: 10.1093/Femsle/Fnv053 |
0.64 |
|
2015 |
Beatson SA, Ben Zakour NL, Totsika M, Forde BM, Watts RE, Mabbett AN, Szubert JM, Sarkar S, Phan MD, Peters KM, Petty NK, Alikhan NF, Sullivan MJ, Gawthorne JA, Stanton-Cook M, et al. Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition. Infection and Immunity. 83: 1749-64. PMID 25667270 DOI: 10.1128/IAI.02810-14 |
0.01 |
|
2015 |
Adams LA, Sharma P, Mohanty B, Ilyichova OV, Mulcair MD, Williams ML, Gleeson EC, Totsika M, Doak BC, Caria S, Rimmer K, Horne J, Shouldice SR, Vazirani M, Headey SJ, et al. Application of fragment-based screening to the design of inhibitors of Escherichia coli DsbA. Angewandte Chemie (International Ed. in English). 54: 2179-84. PMID 25556635 DOI: 10.1002/anie.201410341 |
0.01 |
|
2015 |
Wurpel DJ, Moriel DG, Totsika M, Easton DM, Schembri MA. Comparative analysis of the uropathogenic Escherichia coli surface proteome by tandem mass-spectrometry of artificially induced outer membrane vesicles Journal of Proteomics. 115: 93-106. PMID 25534882 DOI: 10.1016/j.jprot.2014.12.005 |
0.01 |
|
2015 |
Mavromatis CH, Bokil NJ, Totsika M, Kakkanat A, Schaale K, Cannistraci CV, Ryu T, Beatson SA, Ulett GC, Schembri MA, Sweet MJ, Ravasi T. The co-transcriptome of uropathogenic Escherichia coli-infected mouse macrophages reveals new insights into host-pathogen interactions. Cellular Microbiology. 17: 730-46. PMID 25410299 DOI: 10.1111/cmi.12397 |
0.04 |
|
2014 |
Forde BM, Ben Zakour NL, Stanton-Cook M, Phan MD, Totsika M, Peters KM, Chan KG, Schembri MA, Upton M, Beatson SA. The complete genome sequence of Escherichia coli EC958: a high quality reference sequence for the globally disseminated multidrug resistant E. coli O25b:H4-ST131 clone. Plos One. 9: e104400. PMID 25126841 DOI: 10.1371/journal.pone.0104400 |
0.04 |
|
2014 |
Sarkar S, Ulett GC, Totsika M, Phan MD, Schembri MA. Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli. Plos One. 9: e94786. PMID 24722484 DOI: 10.1371/journal.pone.0094786 |
0.01 |
|
2014 |
Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan MD, Gomes Moriel D, Peters KM, Davies M, Rogers BA, Dougan G, Rodriguez-Baño J, Pascual A, Pitout JD, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proceedings of the National Academy of Sciences of the United States of America. 111: 5694-9. PMID 24706808 DOI: 10.1073/Pnas.1322678111 |
0.01 |
|
2014 |
Wurpel DJ, Totsika M, Allsopp LP, Hartley-Tassell LE, Day CJ, Peters KM, Sarkar S, Ulett GC, Yang J, Tiralongo J, Strugnell RA, Jennings MP, Schembri MA. F9 fimbriae of uropathogenic Escherichia coli are expressed at low temperature and recognise Galβ1-3GlcNAc-containing glycans. Plos One. 9: e93177. PMID 24671091 DOI: 10.1371/journal.pone.0093177 |
0.01 |
|
2014 |
Heras B, Totsika M, Peters KM, Paxman JJ, Gee CL, Jarrott RJ, Perugini MA, Whitten AE, Schembri MA. The antigen 43 structure reveals a molecular Velcro-like mechanism of autotransporter-mediated bacterial clumping. Proceedings of the National Academy of Sciences of the United States of America. 111: 457-62. PMID 24335802 DOI: 10.1073/pnas.1311592111 |
0.01 |
|
2013 |
Phan MD, Peters KM, Sarkar S, Lukowski SW, Allsopp LP, Gomes Moriel D, Achard ME, Totsika M, Marshall VM, Upton M, Beatson SA, Schembri MA. The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. Plos Genetics. 9: e1003834. PMID 24098145 DOI: 10.1371/Journal.Pgen.1003834 |
0.04 |
|
2013 |
Goh HM, Beatson SA, Totsika M, Moriel DG, Phan MD, Szubert J, Runnegar N, Sidjabat HE, Paterson DL, Nimmo GR, Lipman J, Schembri MA. Molecular analysis of the Acinetobacter baumannii biofilm-associated protein. Applied and Environmental Microbiology. 79: 6535-43. PMID 23956398 DOI: 10.1128/AEM.01402-13 |
0.04 |
|
2013 |
Totsika M, Kostakioti M, Hannan TJ, Upton M, Beatson SA, Janetka JW, Hultgren SJ, Schembri MA. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. The Journal of Infectious Diseases. 208: 921-8. PMID 23737602 DOI: 10.1093/Infdis/Jit245 |
0.04 |
|
2013 |
Nethercott C, Mabbett AN, Totsika M, Peters P, Ortiz JC, Nimmo GR, Coombs GW, Walker MJ, Schembri MA. Molecular characterization of endocarditis-associated Staphylococcus aureus. Journal of Clinical Microbiology. 51: 2131-8. PMID 23616460 DOI: 10.1128/JCM.00651-13 |
0.01 |
|
2013 |
Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, Schembri MA. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Current Opinion in Microbiology. 16: 100-7. PMID 23403118 DOI: 10.1016/j.mib.2013.01.005 |
0.04 |
|
2013 |
Wurpel DJ, Beatson SA, Totsika M, Petty NK, Schembri MA. Chaperone-usher fimbriae of Escherichia coli. Plos One. 8: e52835. PMID 23382825 DOI: 10.1371/journal.pone.0052835 |
0.01 |
|
2012 |
Allsopp LP, Beloin C, Moriel DG, Totsika M, Ghigo JM, Schembri MA. Functional heterogeneity of the UpaH autotransporter protein from uropathogenic Escherichia coli. Journal of Bacteriology. 194: 5769-82. PMID 22904291 DOI: 10.1128/JB.01264-12 |
0.01 |
|
2012 |
Watts RE, Tan CK, Ulett GC, Carey AJ, Totsika M, Idris A, Paton AW, Morona R, Paton JC, Schembri MA. Escherichia coli 83972 expressing a P fimbriae oligosaccharide receptor mimic impairs adhesion of uropathogenic E. coli. The Journal of Infectious Diseases. 206: 1242-9. PMID 22872729 DOI: 10.1093/infdis/jis493 |
0.01 |
|
2012 |
Vejborg RM, de Evgrafov MR, Phan MD, Totsika M, Schembri MA, Hancock V. Identification of genes important for growth of asymptomatic bacteriuria Escherichia coli in urine. Infection and Immunity. 80: 3179-88. PMID 22753377 DOI: 10.1128/IAI.00473-12 |
0.01 |
|
2012 |
Totsika M, Moriel DG, Idris A, Rogers BA, Wurpel DJ, Phan MD, Paterson DL, Schembri MA. Uropathogenic escherichia coli mediated urinary tract infection Current Drug Targets. 13: 1386-1399. PMID 22664092 DOI: 10.2174/138945012803530206 |
0.01 |
|
2012 |
Selkrig J, Mosbahi K, Webb CT, Belousoff MJ, Perry AJ, Wells TJ, Morris F, Leyton DL, Totsika M, Phan MD, Celik N, Kelly M, Oates C, Hartland EL, Robins-Browne RM, et al. Discovery of an archetypal protein transport system in bacterial outer membranes. Nature Structural & Molecular Biology. 19: 506-10, S1. PMID 22466966 DOI: 10.1038/nsmb.2261 |
0.01 |
|
2012 |
Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. Fems Microbiology Reviews. 36: 616-48. PMID 22404313 DOI: 10.1111/J.1574-6976.2012.00339.X |
0.01 |
|
2012 |
Totsika M, Wells TJ, Beloin C, Valle J, Allsopp LP, King NP, Ghigo JM, Schembri MA. Molecular characterization of the EhaG and UpaG trimeric autotransporter proteins from pathogenic Escherichia coli. Applied and Environmental Microbiology. 78: 2179-89. PMID 22286983 DOI: 10.1128/AEM.06680-11 |
0.01 |
|
2012 |
King NP, Sakinç T, Ben Zakour NL, Totsika M, Heras B, Simerska P, Shepherd M, Gatermann SG, Beatson SA, Schembri MA. Characterisation of a cell wall-anchored protein of Staphylococcus saprophyticus associated with linoleic acid resistance. Bmc Microbiology. 12: 8. PMID 22243671 DOI: 10.1186/1471-2180-12-8 |
0.01 |
|
2012 |
Abraham S, Chapman TA, Zhang R, Chin J, Mabbett AN, Totsika M, Schembri MA. Molecular characterization of Escherichia coli strains that cause symptomatic and asymptomatic urinary tract infections. Journal of Clinical Microbiology. 50: 1027-30. PMID 22189125 DOI: 10.1128/JCM.06671-11 |
0.01 |
|
2012 |
Duell BL, Carey AJ, Tan CK, Cui X, Webb RI, Totsika M, Schembri MA, Derrington P, Irving-Rodgers H, Brooks AJ, Cripps AW, Crowley M, Ulett GC. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. Journal of Immunology (Baltimore, Md. : 1950). 188: 781-92. PMID 22184725 DOI: 10.4049/Jimmunol.1101231 |
0.01 |
|
2012 |
Allsopp LP, Beloin C, Ulett GC, Valle J, Totsika M, Sherlock O, Ghigo JM, Schembri MA. Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073. Infection and Immunity. 80: 321-32. PMID 21930758 DOI: 10.1128/IAI.05322-11 |
0.01 |
|
2012 |
Watts RE, Totsika M, Challinor VL, Mabbett AN, Ulett GC, De Voss JJ, Schembri MA. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infection and Immunity. 80: 333-44. PMID 21930757 DOI: 10.1128/IAI.05594-11 |
0.01 |
|
2011 |
Totsika M, Beatson SA, Sarkar S, Phan MD, Petty NK, Bachmann N, Szubert M, Sidjabat HE, Paterson DL, Upton M, Schembri MA. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. Plos One. 6: e26578. PMID 22053197 DOI: 10.1371/journal.pone.0026578 |
0.04 |
|
2011 |
Bokil NJ, Totsika M, Carey AJ, Stacey KJ, Hancock V, Saunders BM, Ravasi T, Ulett GC, Schembri MA, Sweet MJ. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Immunobiology. 216: 1164-71. PMID 21802164 DOI: 10.1016/j.imbio.2011.05.011 |
0.01 |
|
2011 |
Easton DM, Totsika M, Allsopp LP, Phan MD, Idris A, Wurpel DJ, Sherlock O, Zhang B, Venturini C, Beatson SA, Mahony TJ, Cobbold RN, Schembri MA. Characterization of EhaJ, a New Autotransporter Protein from Enterohemorrhagic and Enteropathogenic Escherichia coli. Frontiers in Microbiology. 2: 120. PMID 21687429 DOI: 10.3389/fmicb.2011.00120 |
0.08 |
|
2011 |
King NP, Beatson SA, Totsika M, Ulett GC, Alm RA, Manning PA, Schembri MA. UafB is a serine-rich repeat adhesin of Staphylococcus saprophyticus that mediates binding to fibronectin, fibrinogen and human uroepithelial cells. Microbiology (Reading, England). 157: 1161-75. PMID 21252279 DOI: 10.1099/mic.0.047639-0 |
0.01 |
|
2011 |
Shouldice SR, Heras B, Walden PM, Totsika M, Schembri MA, Martin JL. Structure and function of DsbA, a key bacterial oxidative folding catalyst. Antioxidants & Redox Signaling. 14: 1729-60. PMID 21241169 DOI: 10.1089/ars.2010.3344 |
0.01 |
|
2011 |
Pope PB, Totsika M, Aguirre de Carcer D, Schembri MA, Morrison M. Muramidases found in the foregut microbiome of the Tammar wallaby can direct cell aggregation and biofilm formation. The Isme Journal. 5: 341-50. PMID 20668486 DOI: 10.1038/ismej.2010.116 |
0.04 |
|
2011 |
Thompson MF, Totsika M, Schembri MA, Mills PC, Seton EJ, Trott DJ. Experimental colonization of the canine urinary tract with the asymptomatic bacteriuria Escherichia coli strain 83972. Veterinary Microbiology. 147: 205-8. PMID 20638202 DOI: 10.1016/j.vetmic.2010.06.007 |
0.01 |
|
2011 |
Easton DM, Totsika M, Allsopp LP, Phan MD, Idris A, Wurpel DJ, Sherlock O, Zhang B, Venturini C, Beatson SA, Mahony TJ, Cobbold RN, Schembri MA. Characterization of EhaJ, a new autotransporter protein from enterohemorrhagic and enteropathogenic Escherichia coli Frontiers in Microbiology. 2. DOI: 10.3389/fmicb.2011.00120 |
0.01 |
|
2010 |
Ong CL, Beatson SA, Totsika M, Forestier C, McEwan AG, Schembri MA. Molecular analysis of type 3 fimbrial genes from Escherichia coli, Klebsiella and Citrobacter species. Bmc Microbiology. 10: 183. PMID 20576143 DOI: 10.1186/1471-2180-10-183 |
0.01 |
|
2010 |
Wells TJ, Totsika M, Schembri MA. Autotransporters of Escherichia coli: a sequence-based characterization. Microbiology (Reading, England). 156: 2459-69. PMID 20447993 DOI: 10.1099/mic.0.039024-0 |
0.01 |
|
2010 |
Watts RE, Hancock V, Ong CL, Vejborg RM, Mabbett AN, Totsika M, Looke DF, Nimmo GR, Klemm P, Schembri MA. Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties. Journal of Clinical Microbiology. 48: 2449-58. PMID 20444967 DOI: 10.1128/JCM.01611-09 |
0.01 |
|
2010 |
Heras B, Totsika M, Jarrott R, Shouldice SR, Gunčar G, Achard MES, Wells TJ, Argente MP, McEwan AG, Schembri MA. Structural and functional characterization of three DsbA paralogues from Salmonella enterica serovar typhimurium Journal of Biological Chemistry. 285: 18423-18432. PMID 20233716 DOI: 10.1074/jbc.M110.101360 |
0.01 |
|
2010 |
Allsopp LP, Totsika M, Tree JJ, Ulett GC, Mabbett AN, Wells TJ, Kobe B, Beatson SA, Schembri MA. UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infection and Immunity. 78: 1659-69. PMID 20145097 DOI: 10.1128/IAI.01010-09 |
0.01 |
|
2009 |
Wells TJ, McNeilly TN, Totsika M, Mahajan A, Gally DL, Schembri MA. The Escherichia coli O157:H7 EhaB autotransporter protein binds to laminin and collagen I and induces a serum IgA response in O157:H7 challenged cattle. Environmental Microbiology. 11: 1803-14. PMID 19508554 DOI: 10.1111/j.1462-2920.2009.01905.x |
0.01 |
|
2009 |
Totsika M, Heras B, Wurpel DJ, Schembri MA. Characterization of two homologous disulfide bond systems involved in virulence factor biogenesis in uropathogenic Escherichia coli CFT073. Journal of Bacteriology. 191: 3901-8. PMID 19376849 DOI: 10.1128/JB.00143-09 |
0.04 |
|
2009 |
Heras B, Shouldice SR, Totsika M, Scanlon MJ, Schembri MA, Martin JL. DSB proteins and bacterial pathogenicity. Nature Reviews. Microbiology. 7: 215-25. PMID 19198617 DOI: 10.1038/nrmicro2087 |
0.01 |
|
2009 |
Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL, Wood JM, Monaghan W, Looke DF, Nimmo GR, Svanborg C, Schembri MA. Virulence properties of asymptomatic bacteriuria Escherichia coli. International Journal of Medical Microbiology : Ijmm. 299: 53-63. PMID 18706859 DOI: 10.1016/j.ijmm.2008.06.003 |
0.01 |
|
2008 |
Valle J, Mabbett AN, Ulett GC, Toledo-Arana A, Wecker K, Totsika M, Schembri MA, Ghigo JM, Beloin C. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. Journal of Bacteriology. 190: 4147-61. PMID 18424525 DOI: 10.1128/JB.00122-08 |
0.01 |
|
2008 |
Totsika M, Beatson SA, Holden N, Gally DL. Regulatory interplay between pap operons in uropathogenic Escherichia coli. Molecular Microbiology. 67: 996-1011. PMID 18208494 DOI: 10.1111/j.1365-2958.2007.06098.x |
0.01 |
|
2007 |
Holden N, Blomfield IC, Uhlin BE, Totsika M, Kulasekara DH, Gally DL. Comparative analysis of FimB and FimE recombinase activity. Microbiology (Reading, England). 153: 4138-4149. PMID 18048927 DOI: 10.1099/mic.0.2007/010363-0 |
0.01 |
|
2007 |
Holden N, Totsika M, Dixon L, Catherwood K, Gally DL. Regulation of P-fimbrial phase variation frequencies in Escherichia coli CFT073. Infection and Immunity. 75: 3325-34. PMID 17452474 DOI: 10.1128/IAI.01989-06 |
0.01 |
|
2006 |
Holden NJ, Totsika M, Mahler E, Roe AJ, Catherwood K, Lindner K, Dobrindt U, Gally DL. Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology (Reading, England). 152: 1143-1153. PMID 16549677 DOI: 10.1099/mic.0.28677-0 |
0.01 |
|
Show low-probability matches. |